Welcome to LookChem.com Sign In|Join Free

CAS

  • or

106790-96-9

Post Buying Request

106790-96-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

106790-96-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 106790-96-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,6,7,9 and 0 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 106790-96:
(8*1)+(7*0)+(6*6)+(5*7)+(4*9)+(3*0)+(2*9)+(1*6)=139
139 % 10 = 9
So 106790-96-9 is a valid CAS Registry Number.
InChI:InChI=1/C13H19IN2O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10H2,1-2H3,(H,15,17)

106790-96-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name N-[2-(Diethylamino)ethyl]-4-iodobenzamide

1.2 Other means of identification

Product number -
Other names (123I)Idab

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:106790-96-9 SDS

106790-96-9Relevant articles and documents

A new strategy for preparing molecular imaging and therapy agents using fluorine-rich (fluorous) soluble supports

Donovan, Amanda,Forbes, Jane,Dorff, Peter,Schaffer, Paul,Babich, John,Valliant, John F.

, p. 3536 - 3537 (2006)

A convenient new strategy for producing radiolabeled compounds in high effective specific activity was developed using soluble fluorous supports. The reported methodology involves a fluorous linker group that is released from the substrate of interest upon reaction with radioiodine. The desired product can then be selectively separated from unreacted starting material and reaction byproducts using a simple fluorous solid-phase extraction procedure. The utility of this approach was demonstrated by labeling a series of benzoic acid derivatives which are commonly used to prepare molecular imaging agents. All compounds were produced in high radiochemical yields, purities, and effective specific activities. The strategy was further elaborated in that it was used to prepare a small collection of radiolabeled benzamides as a way of demonstrating the potential utility of this method for creating libraries of molecular imaging agents. Copyright

Agents for diagnosing and treating melanomas, aromatic halogenated derivatives usable as such agents and their preparation

-

, (2008/06/13)

STR1 The invention concerns agents for diagnosing and treating malignant melanomas, of general formula (I), in which X denotes a hydrogen or halogen atom, Y denotes a Z--CONH--, Z--O--, Z--S(O)--n1 group, n1 being equal to 0,1,2 or 3

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 106790-96-9